Article

Macrophages in the embryo and beyond: Much more than just giant phagocytes

Institute for Molecular Bioscience and Cooperative Research Centre for Chronic Inflammatory Diseases (CRC-CID), University of Queensland, Brisbane, Queensland, Australia
genesis (Impact Factor: 2.04). 09/2008; 46(9):447 - 462. DOI: 10.1002/dvg.20417

ABSTRACT Originally recognized as an essential part of the innate and acquired immune systems, macrophages emerged as omnipresent and influential regulators of embryo- and organo-genesis, as well as of tissue and tumor growth. Macrophages are present essentially in all tissues, beginning with embryonic development and, in addition to their role in host defense and in the clearance of apoptotic cells, are being increasingly recognized for their trophic function and role in regeneration. Some tissue macrophages are also found to posses a substantial potential for autonomous self-renewal. Macrophages are associated with a significant proportion of malignant tumors and are widely recognized for their angiogenesis-promoting and trophic roles, making them one of the new promising targets for cancer therapies. Recent expression profiling of embryonic macrophages from different tissues revealed remarkable consistency of their gene expression profiles, independent of their tissue of origin, as well as their similarities with tumor-associated macrophages. Macrophages are also capable of fusion with other cells in tissue repair and metastasizing tumors, as well as with each other in the immune response and osteoclastogenesis. genesis 46:447–462, 2008. © 2008 Wiley-Liss, Inc.

7 Followers
 · 
1,489 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Lung immaturity due to preterm birth is a significant complication affecting neonatal health. Despite the detrimental effects of supplemental oxygen on alveolar formation, it remains an important treatment for infants with respiratory distress. Macrophages are traditionally associated with the propagation of inflammatory insults, however increased appreciation of their diversity has revealed essential functions in development and regeneration.Methods Macrophage regulatory cytokine Colony-Stimulating Factor-1 (CSF-1) was investigated in a model of neonatal hyperoxia exposure, with the aim of promoting macrophages associated with alveologenesis to protect/rescue lung development and function. Neonatal mice were exposed to normoxia (21% oxygen) or hyperoxia (Hyp; 65% oxygen); and administered CSF-1 (0.5 ¿g/g, daily¿×¿5) or vehicle (PBS) in two treatment regimes; 1) after hyperoxia from postnatal day (P)7-11, or 2) concurrently with five days of hyperoxia from P1-5. Lung structure, function and macrophages were assessed using alveolar morphometry, barometric whole-body plethysmography and flow cytometry.Results and discussionSeven days of hyperoxia resulted in an 18% decrease in body weight and perturbation of lung structure and function. In regime 1, growth restriction persisted in the Hyp¿+¿PBS and Hyp¿+¿CSF-1 groups, although perturbations in respiratory function were resolved by P35. CSF-1 increased CSF-1R+/F4/80+ macrophage number by 34% at P11 compared to Hyp¿+¿PBS, but was not associated with growth or lung structural rescue. In regime 2, five days of hyperoxia did not cause initial growth restriction in the Hyp¿+¿PBS and Hyp¿+¿CSF-1 groups, although body weight was decreased at P35 with CSF-1. CSF-1 was not associated with increased macrophages, or with functional perturbation in the adult. Overall, CSF-1 did not rescue the growth and lung defects associated with hyperoxia in this model; however, an increase in CSF-1R+ macrophages was not associated with an exacerbation of lung injury. The trophic functions of macrophages in lung development requires further elucidation in order to explore macrophage modulation as a strategy for promoting lung maturation.
    Respiratory Research 09/2014; 15(1):110. DOI:10.1186/s12931-014-0110-5 · 3.13 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Activating transcription factor 2 (ATF2) is a member of the leucine zipper family of DNA-binding proteins and is widely distributed in tissues including the liver, lung, spleen, and kidney. Like c-Jun and c-Fos, ATF2 responds to stress-related stimuli and may thereby influence cell proliferation, inflammation, apoptosis, oncogenesis, neurological development and function, and skeletal remodeling. Recent studies clarify the regulatory role of ATF2 in inflammation and describe potential inhibitors of this protein. In this paper, we summarize the properties and functions of ATF2 and explore potential applications of ATF2 inhibitors as tools for research and for the development of immunosuppressive and anti-inflammatory drugs.
    Mediators of Inflammation 06/2014; 2014:950472. DOI:10.1155/2014/950472 · 2.42 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Differentiation of embryonic stem cells can be a useful tool for modeling ontogeny and all the mechanisms involved in its regulation. This is especially true for hematopoiesis where they can recapitulate the two waves observed in embryonic/fetal life: the primitive transient hematopoiesis and the definitive hematopoiesis; both giving rise to distinct morphological and functional cells. This model might be extremely valuable, especially in human to study the ontogeny of the hematopoietic system. My work was focused on the monocyte and macrophage lineages. We have shown that monocyte/macrophage derived from ESC are cells extremely specialized in tissue remodeling, proangiogenesis and immune suppression, but have very low inflammatory potential as demonstrated for embryonic monocyte/macrophage. I have investigated the characteristics of iPSC derived monocyte/macrophage compared to the ESC derived monocyte/macrophage. Results indicate that the monocytes/macrophage obtained from iPSC differentiation were quite similar to those obtained from ESC but exhibited more inflammatory potential, suggesting some incomplete reprogrammation during iPSC generation. We hypothesized that the decrease or absence of inflammatory potential of the monocyte/macrophage cells could be related to a decrease activation of the JAK2/STAT pathway induced by IFN-γ and GM-CSF, two cytokines implicated in M1 polarization. In this purpose we derived iPSC from patient haboring a gain of function mutation, JAK2V617F, associated with myeloproloferative neoplasm. In preliminary results, no significant polarisation differences were observed in JAK2V617F or JAK2WT iPSC derived monocyte/macrophage. Furthermore, we found that IFN-γ was capable to normaly induce STAT1 activation in these cells suggesting that the blockage in inflammatory response is downstream of STAT1 and may be related to epigenetic regulation of inflammatory genes. Finally, I have obtained preliminary results showing tha JAK2V617F may induce an independence to bFGF in the the pluripotent iPSC, a result very similar to those reported by 13 Griffiths et al in JAK2V617F mESC, which could maintain their pluripotent phenotype without addition of LIF. This was not related to the induction of the canonical STAT pathway but to an effect of nuclear JAK2 on the epigenetic regulation of Nanog. These results have to be confirmed and extended but could open a new avenue of research on the role of nuclear JAK2 in MNPs.
    06/2013, Degree: PhD, Supervisor: Norol Francoise, Vainchenker William